(Q34515428)

2 August 2017

1 reference

title

Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses (English)

1 reference

2 August 2017

1 reference

1 reference

1

Gremse DA

0 references

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1663-1670

1 reference

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Economic considerations in the treatment of gastroesophageal reflux disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1663

10.1517/14656566.2.10.1663

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference